Literature DB >> 5753587

Effects of mitomycin c (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.

G E Moore, I D Bross, R Ausman, S Nadler, R Jones, N Slack, A A Rimm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5753587

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  8 in total

1.  Response rates--an evolution.

Authors:  E Poplin; L Baker
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Mitomycin C: experience in the United States, with emphasis on gastric cancer.

Authors:  P S Schein; J S Macdonald; D Hoth; P V Wooley
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 3.  Update on cancer chemotherapy: general considerations and breast cancer. Part II.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-09       Impact factor: 1.798

4.  Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 1.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-04       Impact factor: 1.798

Review 5.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

6.  Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.

Authors:  Seog-Young Kim; Dae-Hee Lee; Xinxin Song; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  Apoptosis       Date:  2014-11       Impact factor: 4.677

7.  Acute Liver Failure Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report.

Authors:  Pavneet Kohli; Prasanth Penumadu; Rajkumar Subramaniam
Journal:  Cureus       Date:  2019-06-28

8.  Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.

Authors:  P A Whitehouse; S J Mercer; L A Knight; F Di Nicolantonio; A O'Callaghan; I A Cree
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.